Pacific Biosciences Of California (PACB) EPS (Basic) Growth (5y) (2015 - 2026)
Pacific Biosciences Of California (PACB) EPS (Basic) Growth (5y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 157.80 Bn | 151.14 Bn | 6.27 Bn |
| 2 | Stryker | 115.54 Bn | 112.66 Bn | 3.81 Bn |
| 3 | Medtronic | 103.44 Bn | 95.27 Bn | 5.76 Bn |
| 4 | Boston Scientific | 72.38 Bn | 71.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 49.76 Bn | 46.09 Bn | 1.29 Bn |
| 6 | Dexcom | 29.53 Bn | 28.42 Bn | 750.30 Mn |
| 7 | GE HealthCare Technologies | 29.51 Bn | 27.44 Bn | 1.98 Bn |
| 8 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 9 | Steris | 20.69 Bn | 20.27 Bn | 697.10 Mn |
| 10 | Pacific Biosciences Of California | 418.97 Mn | 143.01 Mn | 12.84 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 41.82% |
| Dec 31, 2025 | -17.88% |
| Sep 30, 2025 | 1.47% |
| Jun 30, 2025 | 1.37% |
| Mar 31, 2025 | -170.94% |
| Dec 31, 2024 | 16.70% |
| Sep 30, 2024 | -2.98% |
| Jun 30, 2024 | -31.95% |
| Mar 31, 2024 | -7.71% |
| Dec 31, 2023 | -8.10% |
| Sep 30, 2023 | -6.47% |
| Jun 30, 2023 | -10.49% |
| Mar 31, 2023 | -12.47% |
| Dec 31, 2022 | -16.83% |
| Sep 30, 2022 | -12.34% |
| Jun 30, 2022 | -4.24% |
| Mar 31, 2022 | -7.31% |
| Dec 31, 2021 | -10.53% |
| Jun 30, 2021 | 0.00% |
| Mar 31, 2021 | -14.37% |